[ad_1]
Every morning we deliver world news that you want to keep track of before you start your day. Click here to subscribe to the Bloomberg newsletter.
While vaccination of the new coronavirus infection has started in the UK and the US, skepticism about the vaccine runs deep in Japan under the influence of sensational reports of past drug damage and side reactions, for what is spreading to other places. There is a general view that it will lag far behind developed countries.
New Corona Vaccine in the United States (New York, 22)
Photographer: Eric Lee / Bloomberg
“There may be a side reaction in the public mind that the vaccine is blocked.” Tetsuo Nakayama, a specially appointed professor at Kitasato University (virus infection control), points that out. English medical journal in SeptemberA survey of confidence in vaccines published in the Lancet revealed that Japan was one of the lowest countries out of 149 respondents.
Even with the new Corona vaccine, the tendency of the Japanese to avoid it is remarkable. The World Economic Forum and research firm Ipsos jointly target 15 countries.According to the survey, only 69% of Japanese intentions to receive the new corona vaccine were lower than 87% in India and 79% in the UK, and 73% of the overall average.
The government currently has 120 million doses with Pfizer by the end of June next year, 50 million episodes with Moderna by the third quarter of next year, and 120 million episodes with AstraZeneca in the UK (by March next year). . Basically receiving the supply of 30 million times)I have agreed.
Status of obtaining vaccines abroad in Japan
| company name | |
|---|---|
| Pfizer / Biontech |
|
| Modern |
|
| Astra Zeneca / University of Oxford |
|
| Nova Bucks |
|
Source: Prepared by Bloomberg based on materials published by the Ministry of Health, Labor and Social Welfare and other companies.
Pfizer applied for manufacturing and marketing approval in Japan on the 18th and is conducting clinical trials in Japan.We plan to compile the results by February Responsible for the national distribution of the Moderna vaccineTakeda Pharmaceutical Co., Ltd. also plans to start clinical trials in Japan in January next year. Mr. Nakayama said that if the clinical trials currently underway in Japan are successful, they are expected to be approved in March and April.
British research companyAffinity predicts when the new Corona vaccine will be rolled out in each country and region and society will return to everyday life. In Japan, which aims to hold the Olympic and Paralympic Games in Tokyo next year, it is expected to be April 2010, the last among developed countries.
While the Japanese government must approve the vaccine in advance to regain normal economic activity and daily life, it must also proceed with careful deliberations so as not to damage people’s trust.
The shadow of past drug damage
Public sentiment to avoid vaccines has occurred several times in the pastThe harm of drugs is affecting. From 1948 until the following year, the diphtheria vaccine caused health risks for 924 people and the death of 83 due to errors by the manufacturing company. From 1989 to 1993, many children were infected with aseptic meningitis due to vaccination with the Shika, Otafukukaze, and Fushin (MMR) vaccines, resulting in around 1800 victims.
In this context, the revised Immunization Act of 1994 changed the “compulsory vaccination” imposed to regular vaccines by “compulsory effort”.changed. In recent years, side reactions to vaccination to prevent infection with the human papillomavirus (HPV), which causes cervical cancer, have become a hot topic.
Mikito Tanaka, an associate professor at Waseda University’s School of Political Economy (Society for Science and Technology), says he is concerned about the impact of broad shows, which tend to report sensationally. While the elderly benefit the most from the vaccine, the extensive program has become an important source of information for the elderly, he said.
Haruka Sakamoto, a specially appointed researcher at the University of Tokyo Graduate School of Public Health, notes that the government and the media must play an active role in public relations to popularize the inoculation of the new corona vaccine. He clarified that the role that each of the HPV vaccines plays is important, citing the case in which the media took a large number of side reactions and the government ultimately withheld active recommendations.
He added that although vaccine evasion exists in all countries, “the difference is the way the media reports should be and the government’s position on it.”
The government recommends vaccination
Shuichiro Hayashi, director of the Office of Immunization, Health Division, Office of Health, Ministry of Health, Labor and Welfare, said that the vaccination of the new crown is recommended in the Immunization Law. He said documents are likely to be distributed through local government to encourage people who want to get the vaccine.
At a meeting on the 18th, Health, Labor and Welfare Minister Norihisa Tamura said that medical staff will prioritize inoculation after approval of the Pfizer vaccine, saying that “we would like to firmly improve the system.” so that inoculation can be done as soon as possible.
In Europe and the United States, where vaccination of the new crown has already started, some of the people who received the vaccine jointly developed by Pfizer and Germany’s Biontech had side reactions in the United Kingdom, and two in Alaska in the United States had similar reactions . It was reported that he was seen.
After that, the Vice President of the United States, Mike Pence, received a public vaccination of the vaccine, which was broadcast on American television to make an appeal to the public about its safety, and the next President Joe Byden will be vaccinated.Was published.
